• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Infographic: Do Formulary Drug Exclusions Save Money as Promised?

Article

Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs.

At the beginning of August, Express Scripts and CVS Health announced formulary exclusions aimed at battling rising prescription drug prices. Notably, diabetes drugs took a hit with Express Scripts choosing not to cover Victoza and CVS Health announcing is would pull Lantus, along with its successor Toujeo, in favor of the biosimilar Basaglar.

Researchers from Tufts Medical Center analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs. They found that in most cases, exclusion policies work.

However, while most studies suggested that drug exclusions save money, in some cases savings from less expensive alternatives were offset by other healthcare spending, such as increased office visits or hospitalizations.

Read the full study.

Related Videos
Amit Singal, MD, UT Southwestern Medical Center
Rashon Lane, PhD, MA
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Beau Raymond, MD
Dr Sophia Humphreys
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Ryan Stice, PharmD
Raajit Rampal, MD, PhD, screenshot
Leslie Fish, PharmD.
Ronesh Sinha, MD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.